| 今开：28.57 | 昨收：28.27 |
| 最高：28.765 | 最低：27.93 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.655749715E9 |
产业链观察03-11 21:20
#药闻简讯# 2024 年 3 月 11 日/Protagonist Therapeutics, Inc$Protagonist(PTGX)$ 今天在美国皮肤病学会（AAD）2024 年年会上宣布了一项重大突破，即对 JNJ-2113 进行 2b 期 FRONTIER 2 长期扩展研究的积极结果，JNJ-2113 是首个也是唯一一个用于阻断 IL-23 受体的研究性靶向口服肽，适用于中重...查看全文
Protagonist(PTGX)04-27 04:35
$Protagonist(PTGX)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-052999 Act: 34 Size: 2 MB 网页链接查看全文
Protagonist(PTGX)04-27 04:45
$Protagonist(PTGX)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-053023 Act: 34 Size: 2 MB 网页链接查看全文
Protagonist(PTGX)04-13 04:35
$Protagonist(PTGX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-046797 Act: 34 Size: 2 MB 网页链接查看全文
Protagonist(PTGX)02-28 05:55
$Protagonist(PTGX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-028247 Act: 33 Size: 79 KB 网页链接查看全文
Protagonist(PTGX)02-29 09:05
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-028888 Size: 5 KB 网页链接查看全文
Protagonist(PTGX)02-14 22:35
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000437 Act: 34 Size: 280 KB 网页链接查看全文
Protagonist(PTGX)02-15 06:05
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023959 Act: 34 Size: 138 KB 网页链接查看全文
Protagonist(PTGX)02-14 20:25
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001553 Act: 34 Size: 65 KB 网页链接查看全文
Protagonist(PTGX)03-01 06:55
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000257 Act: 33 Size: 4 KB 网页链接查看全文
Protagonist是一个市值10亿美元左右，市净率3倍多的与强生有重要合作的公司，我之前不知道这家公司，是看到疑夕的微博才注意到这个公司。 这个公司目前17美元/股，前底4美元多，足足涨了4倍多，即便从最近8美元左右，也是3个季度翻倍... 网页链接
$Protagonist(PTGX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007081 Act: 34 Size: 6 MB 网页链接
$Protagonist(PTGX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-058036 Act: 34 Size: 301 KB 网页链接
$Protagonist(PTGX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-053013 Act: 34 Size: 470 KB 网页链接
$Protagonist(PTGX)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-053023 Act: 34 Size: 2 MB 网页链接
$Protagonist(PTGX)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-052999 Act: 34 Size: 2 MB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-049567 Size: 5 KB 网页链接
$Protagonist(PTGX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-046797 Act: 34 Size: 2 MB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-042744 Size: 5 KB 网页链接
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000271 Act: 33 Size: 5 KB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-033132 Size: 6 KB 网页链接